Thus, the autocrine PD-1 antibody relieved the suppressive effect of the inhibitory TME on γδ T cells and thus significantly augmented therapeutic efficacy in ovarian tumor-bearing mice. Here, PDCD1 is linked to ovarian neoplasm.